New planning bill could be the government’s most important – but will it work in practice?
FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%
FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%
The drug middlemen known as pharmacy-benefit managers took another body blow from regulators on Tuesday, as they were criticized for charging way more for some “critical” prescription drugs than it cost them.
